濮阳东方医院看早泄比较好(濮阳东方医院看阳痿非常可靠) (今日更新中)

BEIJING, Jan. 25 (Xinhua) -- A senior Chinese official has encouraged the country's young jurists to more actively participate in the country's legislative process and better serve the practice of law enforcement.Zhou Yongkang, a member of the Standing Committee of the Political Bureau of the Communist Party of China (CPC) Central Committee, made the remarks in meeting with outstanding youth law science experts on Tuesday in Beijing.Zhou said young experts on law science should pay more attention to practical problems in China's legal construction and propose more insights, advice and suggestions.Young experts should study more problems encountered by common people and better serve the people with their knowledge, Zhou said.Ten experts on law science from the Renmin University of China, China University of Political Science and Law and other universities and Chinese Academy of Social Sciences were awarded the honor of national outstanding young jurists by the China Law Society.

BEIJING, May 19 (Xinhuanet) -- LinkedIn said Wednesday that its stock will debut at 45 U.S. dollars per share, a higher price than the company was expecting even earlier this week, media reports said.The first major U.S. social networking firm to go public, LinkedIn jacked up its initial public offering (IPO) share price for 7.84 million shares to 45 dollars just a week after it first set a target of 32-35 dollars per share.It minted LinkedIn with a market value of more than 4 billion dollars, the highest for a U.S. Internet company taking its first bow on Wall Street since Google Inc. went public nearly seven years ago.The sale could bring in more than 354 million dollars. The company's shares are expected to begin trading on the New York Stock Exchange on Thursday under the symbol "LNKD".LinkedIn has more than 100 million members in over 200 countries and territories. In 2010, the company made 15 million dollars in profit on 243 million dollars in revenue, according to its SEC filing.LinkedIn's biggest shareholder is its founder and chairman, Reid Hoffman, who owns more than 21 percent of the company.

COPENHAGEN, April 30 (Xinhua) -- As traditional Chinese medicine (known as TCM in Europe) becomes increasingly popular worldwide and has gradually been regarded as a useful component to Western medical treatments, Denmark is no stranger to such trends.According to a study published by the University of Copenhagen in mid-Feb., up to one-third of Danish hospitals choose complementary or alternative therapies, including TCM methods, to treat pain, cancer, mental disease, tumors and infertility. Acupuncture remains the most widely-practiced form of these treatments, used in some 97 percent of the cases.The nationwide acceptance of acupuncture and massage therapists, the growing ranks of herbal practitioners, and the hosting of an annual pan-Scandinavian TCM conference since 2007, all underline the popularity of alternative medicine, including the TCM, in the country.However, the overall market presence of TCM, and herbal medicines in particular, is relatively small in Denmark and Europe at large. As many European policymakers insist that traditional herbal medicines "are neither scientifically documented nor tested according to Western requirements," these treatments face difficulties in obtaining licenses and boosting sales in Europe.In fact, despite their historical pedigree and widely-accepted efficacy, TCM products are often classified as "healthcare products" or "food," rather than "drugs" in European markets.A big challenge for TCM products to gain more access to the continent is the EU's Traditional Herbal Medicinal Products Directive, which stipulates that all such products must obtain authorization if they are to be sold within the EU, starting May 1, 2011.The directive says producers must prove the product in question has been used for 30 years, 15 of which within the EU, so as to ensure its safety.While licensing is expected to be onerous and expensive, Denmark has tried to bring TCM products into the Western medical mainstream from as early as 2005. The country's well-developed biochemical and medical industry, modernized agriculture and horticulture sectors and a strong track record of cooperative research in these fields, has helped TCM's cause.For instance, Traditional Complementary Medicine Denmark, a company helping herbal product makers market their goods in Western countries, uses modern biotechnology processes and clinical trials to scientifically verify and document the efficacy of existing herbal medicines.It also advises herbal product makers on how to align their standards with European requirements so as to acquire the necessary sales licenses. Sometimes, simple solutions like clearer and more detailed labeling of a TCM product's ingredients can help improve its marketability. Patent applications and drug approvals procedures must follow, before the product can access the EU pharmaceutical market, usually in pill form.Investing in herbal medicine also makes financial sense for Denmark, as it is encourages development of low-bulk, high-value agricultural products, which can be easily transported all over the globe.Development Centre Aarslev, a Danish agro-research body and partner of TCM Denmark, studies the active ingredients contained in medicinal plants and their impact on human health conditions such as cardiovascular problems, diabetes and allergies. One of the earliest collaborations it undertook with a producer of herbal medicine showed the effectiveness of extracts from the hips of the dog rose plant in treating rheumatoid arthritis.A spokesperson for the institution said, "We have documented analytical evidence which shows that arthritis patients can reduce their consumption of conventional anti-arthritis drugs by up to 50 percent, if they combine them with the herbal drug based on dog rose hips."Given Denmark's population of 5.5 million people, this could translate into savings of 200 million U.S. dollars a year on anti-arthritis medication, the spokesperson added.Other plant-based interventions could hold wider public health benefits. TCM practitioners say herbal medicines can improve blood circulation in humans, and contain naturally-occurring antioxidants which can reduce the risks of heart attacks and better regulate cardiovascular functions. This has potentially wide-ranging benefit for Western societies, where heart disease is a major threat.Heart disease was the most common cause of death in Denmark until 2000, and cardiovascular disease the commonest until 2008, with cancer now ranking the biggest killer.In fact, TCM herbal remedies are also considered a good choice for cancer treatment, as certain plants contain hormone-like substance which can influence hormone-dependent cancers, such as breast and prostate cancer.TCM supporters say the obvious benefit of such an intervention is the avoidance of more commonly-used chemotherapy and radiation treatments which often produce severe side-effects in patients. Relevant herbal therapies can help strengthen cancer patient's immune system, reduce side-effects of chemotherapy and radiation therapy, and alleviate other symptoms of the disease.Given the many potential benefits of TCM, the EU's tightening of rules may appear harsh. Still, TCM is considered a relatively novel approach to medicine in Europe. Moreover, the dominant market share and general clout of the chemical-based, Western pharmaceutical industry also makes it difficult for traditional remedies to stake their claim.

JINAN, May 14 (Xinhua) -- Chinese scientists said Saturday that they have found a new species of giant theropod dinosaur in the eastern province of Shandong.The new species, described as a close relative of Tyrannosaurus rex (T. rex), has been named "Zhuchengtyrannus magnus". Paleontological experts found it has unique upper jawbones after examining the skull and jawbones discovered in the city of Zhucheng.It was estimated to be about 11 meters long and 4 meters tall, weighing close to 7 tonnes."We discovered two kinds of tyrannosaurus fossils here and the identity of the other one still remains unclear," said Xu Xing, a researcher at the Institute of Vertebrate Paleontology and Paleoanthropology under the Chinese Academy of Sciences."We've named the new genus Zhuchengtyrannus magnus, which means the 'Tyrant from Zhucheng' because the bones were found in Zhucheng," Xu said.The bones were a few centimeters smaller than the similar bones in the largest T. Rex specimen, so there was no doubt that Zhuchengtyrannus was a huge tyrannosaur, Xu said.According to Xu, Zhuchengtyrannus magnus belonged to a specialized group of gigantic theropods called tyrannosaurines which existed in North America and eastern Asia during the Late Cretaceous Period that dated back about 65 to 99 million years.All tyrannosaurs were carnivorous, bipedal animals that generally had small arms and large skulls. Among the tyrannosaurs, the tyrannosaurines were the largest and characterized by having just two fingers on each hand and large powerful jaws to deliver a bone crushing bite. They were likely both predators and scavengers.The fossil quarry in Zhucheng contains one of the largest concentrations of dinosaur bones in the world. At least 10 dinosaur species have been found in three rounds of excavations since the 1960s, including Tyrannosaurus and Hadrosaurs.

WASHINGTON, May 25 (Xinhua) -- The number of young adults in the United States with high blood pressure may be much higher than previously reported, according to a new study by researchers at the University of North Carolina (UNC) at Chapel Hill.Researchers analyzed data on more than 14,000 men and women between 24 and 32 years old in 2008 from the National Longitudinal Study of Adolescent Health, known as Add Health. They found 19 percent had elevated blood pressure, also referred to as hypertension. Only about half of the participants with elevated blood pressure had ever been told by a health-care provider that they had the condition."The findings are significant because they indicate that many young adults are at risk of developing heart disease, but are unaware that they have hypertension," said Quynh Nguyen, a doctoral student at UNC's Gillings School of Global Public Health and the study's lead author. Hypertension is a strong risk factor for stroke and coronary heart disease, the leading cause of death for adults in the United States.The findings were published this week in the journal Epidemiology.Kathleen Mullan Harris, Add Health's principal investigator and a co-author of the paper, said the findings were noteworthy because they were from the first nationally representative, field- based study of blood pressure to focus on young adults."The message is clear," said Harris. "Young adults and the medical professionals they visit shouldn't assume they're not old enough to have high blood pressure. This is a condition that leads to chronic illness, premature death and costly medical treatment."

来源：资阳报